I would like to express my sincere gratitude to our shareholders and investors for their understanding and support for our group’s business activities.   In the medical industry, the social security’s finance is getting worse due to our aging society and escalation of medical cost. Therefore, drug and material prices have been reduced as measures to curb medical cost, which leads to intense competition between medical product manufacturers, Under such conditions, our group has launched “3rd medium-term management plan (2011-13)” since last year. It was a milestone year for our business deployment, including DC project*1, MIT business project *2, starting production of Vietnam Create, OEM and strength of the export sales promotion. We will actively continue making efforts to expand sales, production, and development overseas this year.   I would like to ask for the continued support of our shareholders and investors.   *1. DC project …self-manufacture project of Dalian Create Medical Products Co., Ltd *2. MIT project …MIT(Minimally Invasive Therapy), the new brand handles the related products of single port endoscopic surgery January 2012 Shuzo Yoshino President